Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spiro George Rombotis Insider Profile
4 Followers
Spiro George Rombotis, President & CEO, Director at Cyclacel Pharmaceuticals, holds 68.66K shares in Cyclacel Pharmaceuticals (Ticker: CYCC). Most recently, Spiro George Rombotis Bought $6,070 shares of Cyclacel Pharmaceuticals on Dec 26, 2023 for an estimated value of 20.09K.
Spiro George Rombotis Cyclacel Pharmaceuticals (CYCC)President & CEO, Director
Cyclacel Pharmaceuticals (CYCC)
President & CEO, Director
Ranked #90,016 out of 99,335 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-80.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Spiro George Rombotis's holdings
Insider Roles
President & CEO, Director
Roles that Spiro George Rombotis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 22, 2021 - Nov 22, 2022
Return:-79.00%
The most profitable trade made by Spiro George Rombotis
Spiro George Rombotis's Trading History
List of latest transactions for each holding click on a transaction to see Spiro George Rombotis's performance on stock
You May Also Like
Spiro George Rombotis insider profile FAQ
What is the percentage of profitable transactions made by Spiro George Rombotis?
The percentage of profitable transactions made by Spiro George Rombotis is 0%.
What is the average return per transaction made by Spiro George Rombotis?
The average return per transaction made by Spiro George Rombotis is -80.90%.
What stocks does Spiro George Rombotis hold?
Spiro George Rombotis holds: CYCC stocks.
What was Spiro George Rombotis’s latest transaction?
Spiro George Rombotis latest transaction was an Informative Buy of $20.09K.
What was Spiro George Rombotis's most profitable transaction?
Spiro George Rombotis’s most profitable transaction was an Informative Buy of CYCC stock on November 22, 2021. The return on the trade was -79.00%.
What is Spiro George Rombotis's role in Cyclacel Pharmaceuticals?
Spiro George Rombotis's role in Cyclacel Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.